Author

Aditya Patel

MUCOSAL B-CELL EXPANSION AND MATURATION CONTRIBUTE TO ULCERATIVE COLITIS PATHOGENESIS
MUCOSAL B-CELL EXPANSION AND MATURATION CONTRIBUTE TO ULCERATIVE COLITIS PATHOGENESIS

Aditya Patel  et al.

EFFICACY OF DEUCRAVACITINIB, AN ORAL, SELECTIVE, TYROSINE KINASE 2 INHIBITOR, IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS AND PRIOR EXPOSURE TO BIOLOGIC THERAPY: SUBANALYSIS FROM THE PHASE 2 LATTICE-UC STUDY
EFFICACY OF DEUCRAVACITINIB, AN ORAL, SELECTIVE, TYROSINE KINASE 2 INHIBITOR, IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS AND PRIOR EXPOSURE TO BIOLOGIC THERAPY: SUBANALYSIS FROM THE PHASE 2 LATTICE-UC STUDY

Aditya Patel  et al.

Item 1 - 2 / 2
1